×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agendas
Session 4: Master Protocol
Session Chair(s)
Lei Nie, PhD
Director, Division of Biometrics IV, Office of Biostatistics, OTS, CDER
FDA, United States
Speaker(s)
Platform Trials with Bayesian Adaptive Design
Donald A Berry, PhD
M.D. Anderson Cancer Center, United States
Professor, Department of Biostatistics
Regulatory Perspectives on Platform Trials: Lung Map Master Protocol
Hui Zhang, PhD
FDA, United States
Mathematical Statistician
Operational Aspects of Platform Trials: Challenges and Opportunities
Ohad Amit
GlaxoSmithKline, United States
Senior Director, Clinical Statistics
Q&A Panel Discussion<br> Joining the speakers:
Mary Redman, PhD
Fred Hutchinson Cancer Research Center, United States
Lead Biostatistician, SWOG Lung Committee/LungMap, Assoc. Member, Clin Research
Have an account?